comparemela.com

Latest Breaking News On - ஜொனாதன் குஷிங் - Page 1 : comparemela.com

How Much Do We Know about COVID-19 Vaccine Deals? The Quest for Transparent and Equitable Vaccine Deployment

Javier Guzman, Director of Global Health Policy and Senior Policy Fellow, Center for Global Development Jillian Kohler, Director, WHO Collaborating Centre for Governance, Transparency and Accountability in the Pharmaceutical Sector Nicaise Ndembi, Senior Science Advisor, Africa Centres for Disease Control and Prevention Natalie Rhodes, Policy Officer, Transparency International David Wilson, Program Director, Health, Nutrition and Population, World Bank Tom Wright, Senior Programme Officer, Transparency International  Additional speakers to be announced MODERATOR Janeen Madan Keller, Assistant Director of Global Health Policy and Senior Policy Analyst, Center for Global Development ABOUT THE EVENT Policymakers around the world have made the expeditious deployment of safe and effective COVID-19 vaccines a top priority in order to bring the pandemic under control. But how much information about COVID-19 purchasing agreements is actually available in the public domain? And h

Sputnik V controversy: Still no raw data

3 more vaccine developers seek trials in PHL

BusinessWorld May 25, 2021 | 8:18 pm PHILIPPINE STAR/ MICHAEL VARCAS THREE more coronavirus vaccine developers applied for clinical trials in the Philippines, the Department of Science and Technology said on Tuesday. In a press briefing, Science and Technology Undersecretary Rowena Cristina L. Guevara said the task group on vaccine evaluation and selection received clinical trial applications from West China Hospital and Sichuan University, Shenzhen Kangtai Biological Products Co., and Eubiologics Co. Ltd. “Evaluation of the first two new applications are ongoing, while Eubiologics Co. Ltd. are still completing some requirements,” she told an online briefing. The applications are for phase III clinical trials, she said.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.